Acadian Asset Management
TWST icon

Acadian Asset Management’s Twist Bioscience TWST Stock Holding History

Acadian Asset Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Buy
+11,011
New +$716K ﹤0.01% 1228
2026
Q1 		– Sell
-3,653
Closed -$115K – 2260
2025
Q4 		$115K Buy
+3,653
New +$114K ﹤0.01% 1648
2024
Q4 		– Sell
-839
Closed -$37K – 2174
2024
Q3 		$37K Buy
+839
New +$39.9K ﹤0.01% 1886

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Acadian Asset Management's TWST Position: Q2 2026 in Review

Acadian Asset Management opened a new position in Twist Bioscience (TWST) in Q2 2026: 11,011 shares worth $1.13M. The stake represents ﹤0.01% of the portfolio and ranks #1228 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in TWST as recently as Q4 2025.

Acadian Asset Management first reported a position in TWST in Q3 2024 and has held it in 3 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Acadian Asset Management held 11,011 shares of Twist Bioscience worth $1.13M as of Q2 2026.
  • Twist Bioscience was a new Acadian Asset Management position in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1228 holding.
  • Acadian Asset Management first reported a position in Twist Bioscience in Q3 2024 and has held it in 3 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.